This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Teshima, T. et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nature Med. 8, 575–581 (2002).
Weiden, P.L. et al. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. J. Immunol. 116, 1212–1219 (1976).
Storb, R. et al. Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors. Blood 48, 485–490 (1976).
Clift, R.A. et al. A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 82, 2025–2030 (1993).
Antin, J.H. et al. Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. Blood 100, 3479–3482 (2002).
Zhang, Y., Louboutin, J.P., Zhu, J., Rivera, A.J. & Emerson, S.G. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109, 1335–1344 (2002).
Zhang, Y. et al. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J. Immunol. 169, 7111–7118 (2002).
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mielcarek, M., Torok-Storb, B. & Storb, R. Is alloantigen expression by host epithelium required for acute graft-versus-host disease?. Nat Med 9, 150–151 (2003). https://doi.org/10.1038/nm0203-150